GenSight Biologics
Quick facts
Phase 3 pipeline
- GS010 · Ophthalmology / Rare Genetic Disease
GS010 is a gene therapy that delivers a functional copy of the ND4 gene to restore mitochondrial function in retinal cells affected by Leber hereditary optic neuropathy.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: